ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 10,300 shares, a growth of 22.6% from the November 30th total of 8,400 shares. Based on an average daily trading volume, of 12,700 shares, the short-interest ratio is presently 0.8 days.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

BIS stock traded down $0.08 during midday trading on Tuesday, hitting $18.34. The company’s stock had a trading volume of 3,255 shares, compared to its average volume of 14,055. The firm’s 50-day moving average is $16.38 and its 200-day moving average is $15.74. ProShares UltraShort Nasdaq Biotechnology has a 12 month low of $14.05 and a 12 month high of $21.10.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 23rd will be given a dividend of $0.2064 per share. The ex-dividend date is Monday, December 23rd. This is a boost from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC acquired a new position in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned 4.78% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent reporting period.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.